GHIT Fund Helping Pharmaceutical Companies To Develop NTD Treatments
Japan Times: Japanese drugmakers addressing neglected tropical diseases, and not just out of altruism
“…A total of one billion people are currently infected with NTDs, a major obstacle to development in poorer countries. To address the problem, the Global Health Innovative Technology (GHIT) Fund, a Japan-initiated organization, assists in the development of new drugs. … It has subsidized 30 new drug development programs, with six of them now in the clinical trial stage…” (1/6).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.